MTOR and erythema multiforme: Furthermore, differential activation of the PI3K and mTOR pathways, implicated in the development of type I ovarian carcinomas, between OCCC and both EM and serous tumors, may indicate deregulation of the PI3K/mTOR/AKT pathway in OCCC.